Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GMPs Send Smaller Supplement Firms Into Contract Manufacturers’ Arms

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA enforcement of the good manufacturing practices final rule causes some in the supplement industry to question whether small and medium-sized firms can manufacture in-house successfully. Meanwhile, third-party manufacturers are realizing the benefits of a tighter regulatory environment.

Advertisement

Related Content

Basic GMP Failures Will Prompt Heightened FDA Scrutiny
People in Brief
Herbalife Shakes Off Market Dive After Investor Scare
Supplier Qualification Guideline Touts Flexibility, Defers Best Practices
Supplement Firms Should Work Toward Sharing GMP Audits – FDA's Williams
FDA Publishes Small Entity Guide For Supplement GMPs

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS074697

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel